Full name
DOBRY LEK SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ
uses securityreCAPTCHA
47.73.Z - Retail sale of pharmaceutical products
21.10.Z - Manufacture of basic pharmaceutical products
21.20.Z - Manufacture of pharmaceutical preparations and other pharmaceutical products
32.50.Z - Production of medical devices, instruments, and products, including dental products
32.99.Z - Production of other products not classified elsewhere
47.29.Z - Retail trade
47.74.Z - Retail sale of medical and orthopedic products
47.75.Z - Retail sale of cosmetics and toiletries
47.91.Z - Intermediary retail sale, non-specialized
47.99.Z - Retail trade
2022 | 2023 | 2024 | ||
---|---|---|---|---|
K PLN | K PLN | K PLN | % | |
Profit (loss) on sale | 4,5 | -22 | 26,2 | 219,1 |
Gross profit (loss) | 4,5 | -22 | 26,1 | 218,9 |
EBITDA | 4,5 | -22 | 26,2 | 219,1 |
Short time liabilities | 5 | 30,9 | 50,5 | 63,6 |
Other operating costs | 0 | 0 | 0 | 0 |
Equity capital | 4,4 | -17,6 | 8,2 | 146,5 |
Operating profit (EBIT) | 4,5 | -22 | 26,2 | 219,1 |
Assets | 9,4 | 13,3 | 58,7 | 341,5 |
Net profit (loss) | 4,1 | -22 | 25,7 | 217,2 |
Cash | 9,4 | 13 | 57,5 | 343,3 |
Liabilities and provisions for liabilities | 5 | 30,9 | 50,5 | 63,6 |
Net income from sale | 175 | 197 | 593,5 | 201,3 |
Working assets | 9,4 | 13,3 | 58,7 | 341,5 |
Other income costs | 0 | 0 | 0 | -∞ |
Depreciation | 0 | 0 | 0 | 0 |
% | % | % | p.p. | |
Profitability of capital | 92,7 | 125 | 315,2 | 190,2 |
Equity capital to total assets | 46,8 | -132,2 | 13,9 | 146,1 |
Gross profit margin | 2,6 | -11,2 | 4,4 | 15,6 |
EBITDA Margin | 2,6 | -11,2 | 4,4 | 15,6 |
Days | Days | Days | Days | |
Short term commitment turnover cycle | 10 | 57 | 31 | -26 |
Current financial liquidity indicator | 1.880957841873169 | 0.4306022822856903 | 1.1616630554199219 | 0,8 |
Net dept to EBITDA | -2.002800703048706 | 0.572490930557251 | -2.1844186782836914 | -2,8 |
Opinie dotyczące usług, produktów oraz działalności firmy nie są weryfikowane